MedPath

Rehabilitation of Type 2 Diabetes Patients.

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Behavioral: Group based non-pharmacological rehabilitation
Behavioral: Individual non-pharmacological rehabilitation
Registration Number
NCT00284609
Lead Sponsor
Bispebjerg Hospital
Brief Summary

The aim of this study is to investigate the effect of a new rehabilitation program of type 2 diabetes patients in a primary care center versus standard care in the outpatient Hospital Clinic.

Detailed Description

Type 2 diabetes is major and growing health care problem and is associated with premature mortality and increased morbidity. At the time of diagnosis half of the patients have cardiovascular, renal, ophthalmic or neurological disease. A recent Danish intervention study found a marked reduction in cardiovascular events and microvascular complications in a group of patients with type 2 diabetes and microalbuminuria using an intensive multifactorial pharmacologic intervention and lifestyle intervention (3). The achieved changes in lifestyle seems however to vanish after a short period. Lack of information, unawareness of the seriousness of the disease and lack of supervised training and insufficient follow-up may be of importance of the long-term outcome in these patients.

A total number of 180 patients with type 2 diabetes, will be randomized to the intervention group or to standard care.

This study tests an intensive intervention of lifestyle by a newly developed program of rehabilitation compared with routine standards in a randomized controlled design. Provided that a significant positive outcome is found, the non-pharmacologic treatment of type 2 diabetes could be optimized and inpatient hospitalization due to complications could be avoided.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
180
Inclusion Criteria
  • Clinical diagnosis of Type 2 diabetes mellitus
  • HgbA1c between 6,8 - 10,0%
  • With or without one or more micro- and macrovascular or neurological complications.
Exclusion Criteria
  • HgbA1c < 6,8 and > 10,0 %
  • Patients who have attended lifestyle intervention in the past year
  • Patients who is planned to start treatment with insulin during intervention period
  • Lack of motivation
  • Patients with severe heart-, liver or kidney disease or incurable cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Group based non-pharmacological rehabilitation-
2Individual non-pharmacological rehabilitation-
Primary Outcome Measures
NameTimeMethod
Change in HgbA1c (Glycemic control)baseline, six month, one year, two years and three years
Secondary Outcome Measures
NameTimeMethod
fasting total cholesterol, triglycerides, HDL and LDL,baseline, six month, one year, two years and three years
blood pressure,baseline, six month, one year, two years and three years
weight,baseline, six month, one year, two years and three years
waist circumference,baseline, six month, one year, two years and three years
fitness test,baseline, six month, one year, two years and three years
muscle strength test,baseline, six month, one year, two years and three years
occurrence of complications,baseline, six month, one year, two years and three years
inflammatory markers,baseline, six month, one year, two years and three years
beta-cell function test (HOMA-test),baseline, six month, one year, two years and three years
endothelia cell markers,Not yet known
use of medicationbaseline, six month, one year, two years and three years
cost-benefit.Not yet known
Change in Quality of Lifebaseline, six month, one year, two years and three years
Body mass indexbaseline, six month, one year, two years and three years

Trial Locations

Locations (1)

Endocrine Section, Dept Internal Medicine I, Bispebjerg Hospital, University of Copenhagen

🇩🇰

Copenhagen, Copenhagen NV, Denmark

© Copyright 2025. All Rights Reserved by MedPath